Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuro-Oncology

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/neuonc/nor194PMID 22086978PMCID PMC3266380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model

  2011cited by this paper
• Differential responses of human microglia and blood-derived myeloid cells to FTY720.

  2011cited by this paper
• Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain.

  2011influential reference
• Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

  2010cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses

  2010cited by this paper
• Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma.

  2010cited by this paper
• Distinct migratory and cytokine responses of human microglia and macrophages to ATP.

  2010cited by this paper
• The role of microglia in central nervous system immunity and glioma immunology.

  2010cited by this paper
• Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

  2010cited by this paper
• Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.

  2010cited by this paper
• Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages

  2010cited by this paper
• Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo

  2009cited by this paper
• The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.

  2009cited by this paper
• Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy

  2009cited by this paper
• Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

  2009cited by this paper
• Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice

  2009cited by this paper
• Differential migration, LPS‐induced cytokine, chemokine, and NO expression in immortalized BV‐2 and HAPI cell lines and primary microglial cultures

  2008influential reference
• MMPs as therapeutic targets--still a viable option?

  2008cited by this paper
• Case 20-2008: Abdominal pain and weakness after gastric bypass surgery.

  2008cited by this paper
• A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Inhibition of matrix metalloproteinase-9 gene expression by an isoflavone metabolite, irisolidone in U87MG human astroglioma cells.

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Minocycline decreases in vitro microglial motility, β1‐integrin, and Kv1.3 channel expression

  2007cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression

  2007cited by this paper
• Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★

  2006cited by this paper
• The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

  2006cited by this paper
• Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2

  2005cited by this paper
• Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

  2005cited by this paper
• A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: A comparison to 9L gliosarcoma

  2005influential reference
• Determination of subcutaneous tumor size in athymic (nude) mice

  2004cited by this paper
• Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas

  2004cited by this paper
• MCP-1 Expression in CNS-1 Astrocytoma Cells: Implications for Macrophage Infiltration into Tumors In vivo

  2004cited by this paper
• Molecular mechanisms of glioma invasiveness: the role of proteases

  2003cited by this paper
• Differences in multidrug resistance phenotype and matrix metalloproteinases activity between endothelial cells from normal brain and glioma

  2003cited by this paper
• Zymography of Metalloproteinases

  2003cited by this paper
• Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.

  2002cited by this paper
• Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B.

  2002cited by this paper
• Protein Kinase C-ζ Regulates Transcription of the Matrix Metalloproteinase-9 Gene Induced by IL-1 and TNF-α in Glioma Cells via NF-κB*

  2002cited by this paper
• Microglia promote glioma migration

  2002cited by this paper
• Microglial/macrophage expression of interleukin 10 in human glioblastomas

  1999cited by this paper
• High-performance liquid chromatography with peroxyoxalate chemiluminescence determination of propentofylline concentrations in rat brain microdialysate.

  1999cited by this paper
• Clinical trials of propentofylline in vascular dementia

  1999cited by this paper
• Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group.

  1999cited by this paper
• Differential regulation of microglial activation by propentofylline via cAMP signaling.

  1998cited by this paper
• [Neural protective agents, propentofylline (PPF) could induce apoptotic cell death in the human glioma cells: analysis of Bcl-2 and Bax alpha/Bax beta expressions].

  1998cited by this paper
• [Induction of apoptosis through NGF/p75NTR in human glioma cells treated with propentofylline].

  1998cited by this paper
• Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro.

  1997cited by this paper
• Distribution and characterization of microglia/macrophages in human brain tumors

  1996influential reference
• [Up-regulation of NGF, trkA, Fas, down-regulation of bcl-2, and induction of apoptosis by propentofylline in human glioma cell lines].

  1996cited by this paper
• Adenosine and propentofylline inhibit the proliferation of cultured microglial cells.

  1996cited by this paper
• Therapy of adult malignant brain tumors: what have the clinical trials taught us?

  1986cited by this paper
• In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.

  1985cited by this paper

• Targeting ferroptosis with flavonoids for cancer therapy: Mechanisms and opportunities.

  2026cites this paper
• Tumour necrosis factor (TNF) receptor family in GtoPdb v.2025.3

  2025cites this paper
• Targeting immune microenvironment in cervical cancer: current research and advances

  2025cites this paper
• High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma

  2023cites this paper
• Tumour necrosis factor (TNF) receptor family in GtoPdb v.2023.1

  2023cites this paper
• Role of Molecular Targeted Therapeutic Drugs in Treatment of Glioblastoma: A Review Article

  2023cites this paper
• Glioma targeted therapy: insight into future of molecular approaches

  2022cites this paper
• Complementary and Alternative Medicine for Gliomas: Systematic Review and Critical Appraisal of Current Literature

  2022cites this paper
• Regulatory pattern of abnormal promoter CpG island methylation in the glioblastoma multiforme classification

  2022cites this paper
• Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms

  2022cites this paper
• Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword

  2022cites this paper
• The Pivotal Immunoregulatory Functions of Microglia and Macrophages in Glioma Pathogenesis and Therapy

  2022cites this paper
• Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment

  2021cites this paper
• Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma

  2021cites this paper
• Role of Infiltrating Microglia/Macrophages in Glioma.

  2020cites this paper
• Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma

  2020cites this paper
• Characterization and Therapeutic Manipulation of Glioblastoma-Associated Microglia, Macrophages, and Cytokines to Improve Prognosis

  2020cites this paper
• Immunotherapy for glioma: current management and future application.

  2020cites this paper
• Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment

  2020cites this paper
• Targeting Toll like Receptors in Cancer: Role of TLR Natural and Synthetic Modulators.

  2020cites this paper
• Tumour necrosis factor (TNF) receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations

  2019cites this paper
• Immune biology of glioma associated macrophages and microglia: Functional and therapeutic implications.

  2019cites this paper
• Glioma associated microglia/macrophages, a potential pharmacological target to promote antitumor inflammatory immune response in the treatment of glioblastoma

  2018cites this paper
• Glioma Cell and Astrocyte Co-cultures As a Model to Study Tumor–Tissue Interactions: A Review of Methods

  2018cites this paper
• Natural products: a hope for glioblastoma patients

  2018cites this paper
• The metastatic microenvironment: Melanoma–microglia cross‐talk promotes the malignant phenotype of melanoma cells

  2018cites this paper
• Dual role of macrophage in tumor immunity.

  2018cites this paper
• Xanthine scaffold: scope and potential in drug development

  2018cites this paper
• Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma

  2018cites this paper
• Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis

  2017cites this paper
• Preclinical Immunotherapeutic Animal Models for Brain Tumors

  2017cites this paper
• Liposomal temozolomide drug delivery using convection enhanced delivery

  2017cites this paper
• Exploiting Microglial Functions for the Treatment of Glioblastoma.

  2017cites this paper
• Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion

  2017cites this paper
• Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy

  2017cites this paper
• Microglia in Cancer: For Good or for Bad?

  2016cites this paper
• Glioma-secreted soluble factors stimulate microglial activation: The role of interleukin-1β and tumor necrosis factor-α.

  2016cites this paper
• Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway

  2016cites this paper
• Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform.

  2016cites this paper
• Cancer Stem Cells and Tumor-Associated Macrophages

  2016cites this paper
• Hormones and immunity in cancer: are thyroid hormones endocrine players in the microglia/glioma cross-talk?

  2015cites this paper
• Опухолевое микроокружение как мишень терапии злокачественных глиом Tumor microenvironment as a target of malignant gliomas

  2015cites this paper
• HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads

  2015cites this paper
• Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages

  2014cites this paper
• Dissecting the role of Toll-like receptors in microglia-glioma crosstalk

  2014influential citation
• Reactive Oxygen Species‐Dependent Nitric Oxide Production in Reciprocal Interactions of Glioma and Microglial Cells

  2014cites this paper
• Glioma‐associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline

  2014cites this paper
• Effects of propentofylline on CNS remyelination in the rat brainstem

  2014cites this paper
• CNS macrophages and peripheral myeloid cells in brain tumours

  2014cites this paper
• Semapimod Sensitizes Glioblastoma Tumors to Ionizing Radiation by Targeting Microglia

  2014cites this paper
• Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies

  2013cites this paper
• The Controversial Role of Microglia in Malignant Gliomas

  2013cites this paper
• Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model

  2013cites this paper
• NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells

  2013cites this paper
• Novel Mechanisms and Therapeutics in the Treatment for Cancer-Induced Bone Pain

  2013cites this paper
• Review: molecular mechanism of microglia stimulated glioblastoma invasion.

  2013cites this paper
• Multivalent Cathepsin Inhibitor, VBY-825, Attenuates Breast-Induced Bone Cancer Remodelling and Pain

  2013cites this paper
• A DNA Computer for Glioblastoma Multiforme Diagnosis and Drug Delivery

  2013cites this paper
• Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.

  2013cites this paper
• Propentofylline Targets TROY, a Novel Microglial Signaling Pathway

  2012cites this paper